AzTrials
AzTrials

Adolescent Idiopathic ScoliosisNCT07249515

Scapula and Upper Extremity Performance in Scoliosis

An observational study of Adolescent Idiopathic Scoliosis and Upper Extremity, run by Istinye University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

Adolescent Idiopathic Scoliosis s a three-dimensional spinal deformity that may alter shoulder girdle alignment, scapular orientation, and upper extremity biomechanics. Changes in scapular position can influence arm movement, muscle activation, and overall functional performance. Read more about this study

Who is it for?
Ages 10 to 19 years
What is being tested?
Assessment
How many people
20 participants
Where
1 siteTurkey (Türkiye)
Study dates
20 Nov 2025to 28 Feb 2026
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 19 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: The study population consists of adolescents aged 10 to 19 years who have been clinically and radiographically diagnosed with Adolescent Idiopathic Scoliosis. Participants must have a Cobb angle between 10° and 45°, no previous scoliosis-specific conservative treatment, and the physical ability to complete scapular assessment and upper extremity performance testing.

Who may be able to join

  • Diagnosis of Adolescent Idiopathic Scoliosis
  • Age 10-19 years
  • Cobb angle between 10° and 45°
  • No prior scoliosis-specific conservative treatment
  • Ability to participate in physical assessments
  • Voluntary willingness to participate

Who cannot join

  • Neuromuscular, congenital, or syndromic scoliosis
  • Prior spinal surgery
  • Shoulder injury or upper limb pathology affecting performance
  • Neurological or rheumatological disorders
  • Communication or cognitive limitations interfering with testing

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istinye University

    Istanbul, 34010

Other trials in Turkey (Türkiye)

About this study

Official title: ınvestigation of the Relationship Between Scapular Position and Upper Extremity Performance in Adolescents With Idiopathic Scoliosis

Adolescent Idiopathic Scoliosis s a three-dimensional spinal deformity that may alter shoulder girdle alignment, scapular orientation, and upper extremity biomechanics. Changes in scapular position can influence arm movement, muscle activation, and overall functional performance. Understanding these relationships is clinically important for developing effective exercise and rehabilitation strategies.

The aim of this study is to examine the association between scapular position and upper extremity performance in adolescents diagnosed with Adolescent Idiopathic Scoliosis. Scapular dyskinesis, scapular lateral displacement, and upper limb functional performance will be evaluated and correlated with Cobb angle severity. Findings may help clinicians better understand functional impairments linked to scoliosis and support more targeted rehabilitation programs.

Being tested
Assessment
Keywords
Adolescent Idiopathic Scoliosis, Performance, Scapula, upper extremity performance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AssessmentOther

    Participants with Adolescent Idiopathic Scoliosis underwent assessments of scapular dyskinesis, scapular lateral displacement, and upper extremity performance using standardized functional tests.

Study groups in NCT07249515
Study groupRoleWhat they receive
Adolescent Idiopathic Scoliosis GroupParticipants with Adolescent Idiopathic Scoliosis underwent assessments of scapular dyskinesis, scapular lateral displacement, and upper extremity performance using standardized functional tests.
Receives: Other: Assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Medicine Ball Throw Test

    The test will be used to assess upper extremity explosive power. Participants will be positioned in an upright chair without armrests, with their ankles, knees, and hips at 90 degrees. They will be asked to grasp a 3-kg medicine ball with both hands and throw it overhead without bending their bodies forward or flexing their elbows. The first point where the ball touches the floor will be measured from the starting point, and the value will be recorded in cm. The test will be repeated three times, and the average will be recorded. If participants throw the ball down to neck level or by bending forward from the body, the test will be invalid and the test will be repeated.

    Measured: 4 weeks

Secondary outcomes (2)
  1. Scapular Dyskinesis Test

    This is a dynamic test in which the individual, using weights determined by the individual's body weight, actively abducts and flexes their arms bilaterally and with the weight in hand. These movements are repeated several times, and scapular winging, scapular asymmetry, and abnormal movements during these movements indicate the presence of scapular dyskinesis. The type of scapular dyskinesis is determined after these repetitions.

    Measured: 4 weeks

  2. Scapular Lateral Slip Test

    The Scapular Lateral Slip Test, as defined by Kibler, is a semi-dynamic test commonly used to assess the presence of scapular dyskinesis. The individual to be tested was assessed in a standing position with their back turned and open. In the test performed to assess dominant and non-dominant scapular positions, the distance between the spinous process of the T3 vertebra and the medial end of the scapula root (spinal root) and the distance between the spinous process of the T7 vertebra and the inferior end of the scapula were measured with a tape measure and recorded in centimeters (cm). A difference of more than 1.5 cm between the dominant and non-dominant side measurements indicates a positive test.

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Nov 2025
  2. Study start20 Nov 2025
  3. Primary completion15 Feb 2026
  4. Study completion28 Feb 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07249515
Sponsor's protocol ID
25-120
Status last verified
Jun 2026
First submitted
18 Nov 2025
Last updated
26 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in